Top

Drug Safety

Published in:

01-10-2015 | Letter to the Editor

Comment on: “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”

Authors: Mark Cotton, Simone Nicol

Published in: Drug Safety | Issue 10/2015

Excerpt

Dear Editor, …

Bezabhe WM, Bereznicki LR, Chalmers L, Gee P, Kassie DM, Bimirew MA, Peterson GM. Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: a prospective cohort study from Ethiopia. Drug Saf. 2015;38(7):629–39. doi:10.1007/s40264-015-0295-7.CrossRefPubMed

World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2013. http://www.who.int/hiv/pub/guidelines/arv2013/en/. Accessed 20 July 2015.

US Food and Drug Administration (FDA). Preventable adverse drug reactions: a focus on drug interactions. Silver Spring: FDA; 2014. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm110632.htm. Accessed 20 July 2015.

Title: Comment on: “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”
Authors: Mark Cotton
Simone Nicol
Publication date: 01-10-2015
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 10/2015
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.1007/s40264-015-0334-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comment on: “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2015

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update

A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions

15th ISoP Annual Meeting “Cubism in Pharmacovigilance” Prague, Czech Republic 27-30 October, 2015

Benzodiazepine Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis

Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies

Authors’ Reply to Cotton and Nicol’s Comment on “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”